jun 6, 2018: 1:45 p.m. - 2:45 p.m.
Room 210C, Level 2
While machine learning and artificial intelligence (AI) have had a deep impact in solving complex global problems over the past several years, there has been a slow adoption and implementation of these technologies for use in drug discovery R&D. AI-based technologies and platforms in the life sciences are still in their infancy, but this will be the way of the future for generating drugs and diagnostics.
In this panel discussion, we bring together thought-leaders in machine learning and artificial intelligence to delve into the opportunities, capabilities, future trends and challenges of using AI to speed up drug discovery, decrease failure rates in drug trials and create more affordable and better treatments for patients.
Ability Level: Intermediate